Status:
COMPLETED
IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
ImVision AG
Conditions:
Allergy to Cats
Eligibility:
All Genders
18-75 years
Brief Summary
Primary objective of the trial: To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to ...
Eligibility Criteria
Inclusion
- Inclusion criteria: 1. Patient with Cat Dander Allergy evidenced by positive history 2. Age: 18 to 75 years
- Exclusion criteria: 1. Use of oral corticosteroids, Chromoglycin, Ketotifen, or any immunosuppressive drugs within the last 2 months 2. Psychiatric disorder resulting in malcompliance 3. Neg. IgE to Cat dander
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
End Date :
September 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00620880
Start Date
September 1 2005
End Date
September 1 2006
Last Update
November 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zurich, Switzerland